Home/Unity Biotechnology/Michael P. Samar
MP

Michael P. Samar

Chief Development Officer

Unity Biotechnology

Unity Biotechnology Pipeline

DrugIndicationPhase
UBX1325 (foselutoclax)Diabetic Macular Edema (DME)Phase 2b
UBX0101Osteoarthritis of the KneePhase 2
UBX1967Ophthalmology (Undisclosed)Preclinical
CNS ProgramsUndisclosed Neurological DiseasesDiscovery/Preclinical